35 results
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
Recommendations for Preventing ... Women with in HIV-AIDS ... Preventing First ... HumanPapillomavirus #IDSA #Prevention ... #Treatment #management
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
Trypanosomiasis) in HIV-AIDS ... advanced Chagas cardiomyopathy ... duration same as for treatment ... Disease Note: Treatment ... #Treatment #management
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Recommendations for Preventing ... Infections in HIV-AIDS ... Preventing 1st ... or stay for a long ... #Treatment #management
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Summary Acute AIDP ... tachycardia, reversible cardiomyopathy ... GQ1b IgG Antibody associated ... Syndrome #diagnosis #management ... #treatment #neurology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Recommendations for Preventing ... Infections in HIV-AIDS ... Preventing Bacterial ... Bacterial #IDSA #Prevention ... #Treatment #management
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Recommendations for Preventing ... Encephalitis in HIV-AIDS ... Encephalitis #IDSA #Prevention ... #Treatment #opportunistic ... infections #HIVAIDS #management
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
Recommendations for Preventing ... Disease (MCD) in HIV-AIDS ... Preventing Development ... recommended for KS treatment ... #Treatment #management
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Candidiasis in HIV-AIDS ... for effective treatment ... mucosal #IDSA #Prevention ... #Treatment #management
CNS Infection in HIV / AIDS - Differential Diagnosis Framework

Principles of HIV-Associated CNS Opportunistic Infections:
 •
/ AIDS - Differential ... Principles of HIV-Associated ... Antimicrobial treatment ... CNS #Infections #differential ... #diagnosis #AIDS
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
Simplex Virus (HSV ... Infections in HIV-AIDS ... • Continue treatment ... #IDSA #Prevention ... #Treatment #management